You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (22) |
Back to Search
Identification of novel human high-density lipoprotein receptor up-regulators using a cell-based high throughput screening assay
- In: SIG Pharmaceutical Biotechnology - Posters
- At: Beijing (China) (2007)
- Type: Poster
- Poster code: PB-P-015
- By: HONG, Bin (Institute of Medicinal Biotechnology, Beijing, China)
- Co-author(s): Yang, Yuan (Institute of Medicinal Biotechnology, BEIJING, China)
Zhang, Zhongbing (Institute of Medicinal Biotechnology, BEIJING, China)
Jiang, Wei (Institute of Medicinal Biotechnology, BEIJING, China)
Gao, Lei (Institute of Medicinal Biotechnology, BEIJING, China)
Zhao, Guiyu (Institute of Medicinal Biotechnology, BEIJING, China)
Zheng, Zhihui (Institute of Medicinal Biotechnology, BEIJING, China)
Si, Shuyi (Institute of Medicinal Biotechnology, BEIJING, China) - Abstract:
Scavenger receptor class B type I (SR-BI) is the high-affinity HDL receptor, and the CLA-1 is the human homologue of the murine SR-BI. CLA-1/SR-BI receptor has been suggested as a new preventative and/or therapeutic target for atherosclerosis due to its pivotal role in overall HDL cholesterol (HDL-C) metabolism and its anti-atherogenic activity in ..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026